Antiangiogenesis, heralded a while ago as the "magic bullet" to stop cancer growth, has lately entered a reconsideration phase. Results obtained in phase 1 through 3 clinical trials with different ...

One option being investigated is combining 2 or more antiangiogenesis agents or associating treatment with 1 angiogenesis inhibitor and more conventional therapies, such as chemotherapy or ...